About this trial
The purpose of this study is to understand the impact of COVID-19 on patients with cancer through a survey.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
The patients must be 18 years or older.
Patients who opt in to complete the survey.
Patients must have the capacity to verbally consent for the interview.
Disqualifiers
None
Trial population
Individuals who are diagnosed with any cancer diagnosis . We plan to enroll as many patients as possible in the survey portion of the study - we have no limitation of the numbers and do not require a specific number to participate although we hope to achieve at least 50 participants who fill out the survey. Among survey participants, we plan to enroll 18-30 participants in semi-structured telephone interviews. These participants will be randomly selected among those who filled out the survey. The research procedures are as followed: 1. Survey: An online survey link will include questions regarding the impact patients with cancer are experiencing during the coronavirus outbreak. 2. Semi-structured Interviews (18-30 participants): For those participants who state that they would like to participate in an interview, a random sample will be contacted.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Number of participants who fill out the survey and participate in the semi-structured interviews.
We will track the number of participants who fill out the survey for the 12 month duration of the study and the number of participants who participate in the semi-structured telephone interviews.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.